Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant ...

ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in MASLD.

Academia Sinica and NTU Hospital have jointly developed PanMETAI, an AI metabolomics platform for pancreatic cancer detection in early stages.

Ottobock's investment follows a first-in-human implantation of Blue Arbor's neuromuscular interface system using one of the German company's prosthetics.

Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation in patients with syndesmotic disruptions.

Quantum Surgical has acquired NeuWave Medical, supporting its strategy to broaden access to robotic-assisted tumour ablation treatments for reducing cancer mortality.

GE HealthCare has launched its next-generation of LOGIQ ultrasound systems, designed to enhance clinical imaging and expedite workflows.

Guardant's acquisition of MetaSight comes as analysts remain intrigued by the company’s long-term growth prospects.

Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio.

QuidelOrtho has signed a strategic supply agreement with Lifotronic Technology to expand its global immunoassay portfolio.

Knight Therapeutics has announced the regulatory submission of axatilimab in Brazil to treat chronic graft-versus-host disease (cGvHD).

Allurion has received the FDA clearance for PMA application for its Gastric Balloon System featuring the Allurion Smart Capsule for obesity treatment.